In the field of artificial intelligence, machine learning is a branch that uses data and algorithms to imitate human learning. It's an ongoing process in which computers can improve their accuracy ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...
As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a reality.
Using a System76 Thelio Major workstation powered by the AMD Ryzen Threadripper 9980X and running Fedora Workstation 44, I benchmarked all the OpenJDK versions going back to the Java 8 days. Though ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results